Journal of General Internal Medicine

AI startup Carenostics raises $5 million in Seed funding led by M13 to transform healthcare through earlier diagnosis and treatment of chronic disease patients

Retrieved on: 
Thursday, September 14, 2023
Natural language processing, SUA, Asthma, EU, Hackensack Meridian Health, Chronic kidney disease, Health, Disability, Artificial intelligence in healthcare, Association of British HealthTech Industries, Internal medicine, Journal of General Internal Medicine, Mass General Brigham, General partnership, Hackensack, Cerner, MIT, Electronic health record, McKinsey & Company, NLP, Doctor of Philosophy, Hospital, Journal, Patient, EHR, Physician, M13, Healthcare in the United States, Diagnosis, Entrepreneurship, CIO, KPMG, Death, CKD, Computer science, Conditional sentence, Copper, Pharmaceutical industry, Medical device, Nursing, Management, Kanishka, Humana, Amazon, AI

NEW YORK, Sept. 14, 2023 /PRNewswire-PRWeb/ -- Carenostics, a pioneering healthcare AI startup tackling undiagnosed and undertreated chronic disease, has successfully closed a $5 million seed funding round led by M13. Other participants in the round include Greatpoint Ventures, Gaingels, and Kurt Hillzinger, Chairman of Humana, who also joined Carenostics' advisory board.

Key Points: 
  • NEW YORK, Sept. 14, 2023 /PRNewswire-PRWeb/ -- Carenostics, a pioneering healthcare AI startup tackling undiagnosed and undertreated chronic disease, has successfully closed a $5 million seed funding round led by M13.
  • Carenostics, a pioneering healthcare AI startup tackling undiagnosed and undertreated chronic disease, has successfully closed a $5 million seed funding round led by M13.
  • Carenostics has developed a revolutionary AI platform that identifies undiagnosed and undertreated chronic disease patients and prompts clinicians within their current workflows to intervene earlier.
  • He holds a PhD in AI, and previously led Healthcare AI for Siemens and KPMG's US Healthcare & Life Sciences AI & Analytics practice.

IKS Health makes strategic investment in Abridge to launch a partnership that enables the creation of accurate and trusted generative AI models for healthcare

Retrieved on: 
Thursday, May 18, 2023
Software, Practice Management, General Health, Health, Artificial Intelligence, Data Management, Health Technology, Technology, Workforce, Partnership, Synthetic media, Internal medicine, Journal of General Internal Medicine, Certification, HITRUST, Journal, Patient, Physician, FIPS, IKS, Medical device, Abridge

Over the coming months, IKS will leverage Abridge’s generative AI to realize efficiencies in their clinical documentation services.

Key Points: 
  • Over the coming months, IKS will leverage Abridge’s generative AI to realize efficiencies in their clinical documentation services.
  • In turn, IKS will accelerate the development of Abridge’s core AI technologies by contributing feedback from their large workforce of medical professionals.
  • IKS is a healthcare enablement platform focused on assisting US-based healthcare organizations deliver better, safer and cost-effective care through a strategic blend of technology and domain expertise..
  • “Our partnership with Abridge will transform how generative AI will be leveraged in a pragmatic, provider-ready solution that enables them to deliver better, safer and more efficient care at scale."

Crossover Health Publishes First Peer-Reviewed Referral Management Study of its Kind in The Journal of General Internal Medicine

Retrieved on: 
Thursday, August 25, 2022
Mental health, Social media, Journal, Internal medicine, Journal of General Internal Medicine, MD, Â, GLOBE, Springer, Health, Primary health care, SAN, Patient, Health insurance, Crossover

SAN CLEMENTE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Crossover Health , a leader in delivering value-based hybrid care, today published the first peer-reviewed study of referral management among employer-sponsored health centers.

Key Points: 
  • SAN CLEMENTE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Crossover Health , a leader in delivering value-based hybrid care, today published the first peer-reviewed study of referral management among employer-sponsored health centers.
  • Published in The Journal of General Internal Medicine , the study reveals that when referral management via care navigation is embedded in an integrated, team-based model such as the Crossover Primary Health model, self-insured employers should expect to achieve reduced referral rates, increased employee satisfaction and overall reduced costs.
  • There have been very few published studies on the impact of referral management among commercially insured populations and none on referral management from employer-sponsored health centers.
  • To view and download the full The Journal of General Internal Medicine study, visit the Springer website here .

Clarivate Names World's Leading Journals with the 2022 Journal Citation Reports

Retrieved on: 
Tuesday, June 28, 2022
Factor X, Academy, The New England Journal of Medicine, Critical care, Nature Reviews Molecular Cell Biology, SSCI, Publication, Journal, Invention, Research, JCR, Technology, Clarivate, SCIE, Bya, Health and wellbeing board, Book, COVID-19, Internal medicine, Blog, Drug discovery, Sustainable development, Journal Citation Reports, Health care, Final good, Public health, UN, Policy, Infection, Literature, JIF, Journal of General Internal Medicine, List of life sciences, NYSE, Librarian, Editorial, JAMA, The Lancet, Nature Reviews Drug Discovery, Solution, Jif, Vaccine, Professional services, Impact factor, Twitter, American Medical Association, Collection, Pharmaceutical industry, Medical device, Periodical literature, Health, Lancet

LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR)™. The annual JCR release enables the research community to evaluate the world's high-quality academic journals using a range of indicators, descriptive data and visualizations. The reports are used extensively by academic publishers across the globe to understand the scholarly impact of their journals relative to their field and promote them to the research community. 

Key Points: 
  • LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR) .
  • Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and/or citation stacking.
  • Key facts from the 2021 data:
    The Journal Citation Reports contains more than 21,000 journals, from 254 research categories and 114 countries.
  • These include:
    The Journal Citation Indicator, which represents the average category-normalized citation impact for papers published in the prior three-year period.

Clarivate Names World's Leading Journals with the 2022 Journal Citation Reports

Retrieved on: 
Tuesday, June 28, 2022
Factor X, Academy, The New England Journal of Medicine, Critical care, Nature Reviews Molecular Cell Biology, SSCI, Publication, Journal, Invention, Research, JCR, Technology, Clarivate, SCIE, Bya, Health and wellbeing board, Book, COVID-19, Internal medicine, Blog, Drug discovery, Sustainable development, Journal Citation Reports, Health care, Final good, Public health, UN, Policy, Infection, Literature, JIF, Journal of General Internal Medicine, List of life sciences, NYSE, Librarian, Editorial, JAMA, The Lancet, Nature Reviews Drug Discovery, Solution, Jif, Vaccine, Professional services, Impact factor, Twitter, American Medical Association, Collection, Pharmaceutical industry, Medical device, Periodical literature, Health, Lancet

LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR)™. The annual JCR release enables the research community to evaluate the world's high-quality academic journals using a range of indicators, descriptive data and visualizations. The reports are used extensively by academic publishers across the globe to understand the scholarly impact of their journals relative to their field and promote them to the research community. 

Key Points: 
  • LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR) .
  • Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and/or citation stacking.
  • Key facts from the 2021 data:
    The Journal Citation Reports contains more than 21,000 journals, from 254 research categories and 114 countries.
  • These include:
    The Journal Citation Indicator, which represents the average category-normalized citation impact for papers published in the prior three-year period.

Concentrics Research Announces Validation of Health Literacy Instruments for Use in Virtual Environments

Retrieved on: 
Wednesday, March 23, 2022
Journal, Adolescent literacy, Consumer Healthcare Products Association, Data management, Internal medicine, Adolescence, Patient, Compliance, IRB, Tablet, Research, Doctor of Philosophy, Medical writing, Food and Drug Administration, Statistics, CEO, Oxygen concentrator, Food, Health literacy, Technology, Literacy, Data collection, CRO, Regulation, Information technology, Efficiency, Research design, FDA, Bureau of Oceans and International Environmental and Scientific Affairs, Division, Journal of General Internal Medicine, Adult, Medical imaging, Medical device, Medicine

INDIANAPOLIS, March 23, 2022 /PRNewswire/ --Concentrics Research (Indianapolis, INandParsippany, NJ) announces the validation of two widely-used health literacy instruments for use in virtual environments.

Key Points: 
  • INDIANAPOLIS, March 23, 2022 /PRNewswire/ --Concentrics Research (Indianapolis, INandParsippany, NJ) announces the validation of two widely-used health literacy instruments for use in virtual environments.
  • "We have conducted clinical, consumer and patient-focused research for years using the REALM and REALM-Teen health literacy tests in over 1,000 research studies.
  • "To be able to test health literacy virtually marks an important milestone in the innovative use of technology for research studies.
  • The validation has just been published online by the Journal of General Internal Medicine and is accessed as the open-access article, "Evaluating Health Literacy in Virtual Environments: Validation of the REALM and REALM-Teen for Virtual Use" ( https://pubmed.ncbi.nlm.nih.gov/35314964/ ).

Is blood pressure reading more accurate at home or clinic?

Retrieved on: 
Thursday, March 3, 2022
Diagnosis, Patient, Journal, Research, Health education, Health promotion, MPH, Kaiser Permanente, Method, Blood pressure, Internal medicine, Pharmacy, Overdiagnosis, Kidney, Journal of General Internal Medicine, American Heart Association, Stroke, Caregiver, Physician, Health, District, Hypertension, Health information management, ABPM, Randomized controlled trial, Pharmaceutical industry, Medical device, MD

"Blood pressure varies a lot over the day about 30 points systolic and 1 or 2 measurements in clinic may not reflect your average blood pressure," said Beverly B.

Key Points: 
  • "Blood pressure varies a lot over the day about 30 points systolic and 1 or 2 measurements in clinic may not reflect your average blood pressure," said Beverly B.
  • "Home blood pressure monitoring allows you to collect many more readings and average these."
  • In addition to these measures, every participant received 24-hour ambulatory blood pressure monitoring, or ABPM, the gold standard test for making a new diagnosis of hypertension.
  • While the guidelines recommend ABPM or home blood pressure monitoring before making a hypertension diagnosis, research shows that providers continue to use in-clinic measurement when conducting the second reading.

National Kidney Foundation and OptumLabs Call for Changes to Improve Kidney Health

Retrieved on: 
Tuesday, September 7, 2021

NEW YORK, Sept. 7, 2021 /PRNewswire/ --The National Kidney Foundation (NKF) and OptumLabs published today a list of recommendations designed to improve kidney health and kidney disease care in this country.

Key Points: 
  • NEW YORK, Sept. 7, 2021 /PRNewswire/ --The National Kidney Foundation (NKF) and OptumLabs published today a list of recommendations designed to improve kidney health and kidney disease care in this country.
  • Tragically, the COVID-19 pandemic was both devastating to current patients with kidney disease and created new patients with virus-related acute kidney injury.
  • "At OptumLabs we're focused on improving lives and we're honored to be in this fight alongside partners like National Kidney Foundation."
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .

New Study: Removing Patient-Physician Language Barriers Is Associated With Greater Primary Care Utilization, Fewer ER Visits

Retrieved on: 
Tuesday, August 10, 2021
Professional Services, Health, Consumer, Seniors, Insurance, Other Health, General Health, Home, PCP, Journal, Health, CEO, Caregiver, Scan Group, Patient, Pharmacist, Journal of General Internal Medicine, SCAN, Mental health care navigator, Language, Vaccination, Twitter, Population health, Goal, ED, Medicare, Harvard Medical School, Stanford University School of Medicine, Season, SCAN Health Plan, Internal medicine, Health insurance, Hospital

A new study shows that when doctors speak the same language as their patients, patients are more likely to visit their primary care physician (PCP) for preventive and follow-up care, likely resulting in fewer specialist visits, emergency room trips and hospitalizations.

Key Points: 
  • A new study shows that when doctors speak the same language as their patients, patients are more likely to visit their primary care physician (PCP) for preventive and follow-up care, likely resulting in fewer specialist visits, emergency room trips and hospitalizations.
  • The study looked at non-English-speaking members enrolled in SCAN Health Plan, one of the nations largest not-for-profit Medicare Advantage plans.
  • Patient-physician language concordance is associated with greater primary care utilization and lower specialist, inpatient, and ED utilization, the authors concluded.
  • SCAN Health Plan is one of the nations largest not-for-profit Medicare Advantage plans, serving more than 220,000 members in California.